Pamidronate prevents bone loss associated with Carrageenan arthritis by reducing resorptive activity but not recruitment of osteoclasts

Journal of Orthopaedic Research

Volumn 18, Issue 6, 2000, Pages 873-881

  Moran, Erica L ^a   Fornasier, Victor L ^a   Bogoch, Earl R ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; DISEASES; DRUG DOSAGE; JOINTS (ANATOMY); PATIENT TREATMENT;

CARRAGEENAN ARTHRITIS; OSTEOCLASTS; PAMIDRONATE; RHEUMATOID ARTHRITIS; THERAPEUTIC DOSE;

DRUG PRODUCTS;

CALCEIN; CARRAGEENAN; PAMIDRONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; BONE ATROPHY; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; RABBIT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ARTHRITIS; BONE AND BONES; BONE RESORPTION; CARRAGEENAN; DIPHOSPHONATES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; OSTEOCLASTS; OSTEOPOROSIS; RABBITS;

EID: 0034319092     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.1100180605     Document Type: Article

References (40)

1. Studies on the chronic phase of adjuvant arthritis: Effect of SR 41319, a new diphosphonate
2. Bisphosphonate (pamidronate/APD) prevents arthritis-induced loss of fracture toughness in the rabbit femoral diaphysis
3. Juxtaarticular bone loss in experimental inflammatory arthritis
4. Metaphyseal and diaphyseal changes in the femur proximal to the knee in rabbits with experimentally induced inflammatory arthritis of the rabbit knee
5. Two modes of action of bisphosphonates on osteoclastic resorption of mineralized matrix
6. Bisphosphonates in vitro specifically inhibit, among the hematopoietic series, the development of the mouse mononuclear phagocyte lineage
7. Different schedules of administration of (3 amino-1-hydroxypropylidene)- 1, 1 bisphosphonate induce different changes in pig bone remodeling
8. Demonstration of novel anti-arthritic and anti-inflammatory effects of diphosphonates
9. Mechanisms of action of etidronate and other bisphosphonates
10. Increased bone mass with pamidronate treatment in rheumatoid arthritis: Results of a three-year randomized, double-blind trial
11. Aminoalkylbisphosphonates, potent inhibitors of bone resorption, induce a prolonged stimulation of histamine synthesis and increase macrophages, granulocytes, and osteoclasts in vivo
12. Alendronate mechanism of action: Geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro
13. Comparative antiinflammatory and bone protective effects of two diphosphonates in adjuvant arthritis
14. The effects of disodium ethane-1hydroxy-1,1-diphosphonate on adjuvant induced arthritis in rats
15. Efficacious management with aminobisphosphonate (APD) of Paget's Disease of bone
16. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo
17. Effect of dichloromethane diphosphonate on cortisol-induced bone loss in young adult rabbits
18. Treatment of rat arthritides with clodronate-containing liposomes
19. Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins including Ras
20. Double blind radiological assessment of continuous oral pamidronic acid in patients with rheumatoid arthritis
21. Bisphosphonates in collagen arthritis
22. Effects of (3-amino-1hydroxypropylidene)-1, 1-bisphosphonate on mouse osteoclasts
23. Osteoclast recruitment in mice is stimulated by (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate
24. Effects of tiludronate and ibandronate on the secretion of proinflammatory cytokines and nitric oxide from macrophages in vitro
25. Effects of the bisphosphonate zoledronate on bone loss in the ovariectomized and in the adjuvant arthritic rat
26. Contrast between effects of aminobisphosphonates and non-aminobisphosphonates on collagen-induced arthritis in mice
27. Pyrazoline bisphosphonate esters as novel anti-inflammatory antiarthritic agents
28. Effect of clodronate on established collagen-induced arthritis in rats
29. Kinetics studies of bone and mineral metabolism during treatment with (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (APD) in rats
30. Bone histornorphometry: Standardization of nomenclature, symbols, and units. Report of the ASBMS Histomorphometry Nomenclature Committee
31. Altered pore characteristics and geometry in diaphyseal cortical bone affected by inflammatory arthritis
32. Zoledronate (CGP 42'446), a bisphosphonate, protects against metaphyseal intracorticai defects in experimental inflammatory arthritis
33. Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (APD)
34. Kinetic studies of bone and mineral metabolism during treatment with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) in rats
35. Molecular mechanisms of action of bisphosphonates
36. Bisphosphonates act on rat bone resorption through the mediation of osteoblasts
37. Effects of bisphosphonates on isolated rat osteoclasts as examined by reflected light microscopy
38. Cytotoxic and migration inhibitory effects of bisphosphonates on macrophages
39. An in vitro and in vivo study of cytokines in the acute-phase response associated with bisphosphonates
40. Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro